Forus
FO
Forus is an AI-powered medication access network. Its agents automate the administrative work between a doctor prescribing a medication and a patient starting treatment — insurance approvals and prior authorisation, financial assistance, specialty-pharmacy routing and fulfilment — connecting doctors, pharmacies, payers and biopharma on one system. The company was founded in 2023 and operated as Tandem until it took the Forus name in May 2026.
Founded by Sahir Jaggi (Founder, CEO)
Blended valuation$3B
Valuation history
Weekly blended valuation with priced funding rounds marked on the timeline.
$3.2B
blended valuationfunding round
Jun 15, 2026$840MOct 5, 2026
All rounds
3 funding rounds, newest first.
| Round | Announced | Raised | Post-money |
|---|---|---|---|
| Series C | Sep 8, 2026 | $150M | $3B |
| Round | May 13, 2026 | $160M | $1B |
| Series A | Jun 30, 2024 | $37.5M | $172.5M |
Investors
17 investors across all rounds.
- BCBain Capital Ventures
- GCGeneral Catalyst
- ACAccel
- BOBoxGroup
- PVPear VC
- RERedpoint
- TCThrive Capital
- VVVast Ventures
- HCHuman Capital
- NENeo
Only Legion members can view the full investor roster. Sign in to Legion
Invest in the private markets on Legion
Registered users see full trading activity, every investor, rankings, and live deals.
Data as of Oct 16, 2026. Valuations are estimates blended from primary and secondary-market signals — not investment advice.
